Home > Insider Trading > Filing (0001209191-13-044711)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369786	Sagent Pharmaceuticals Inc.	SGNT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251512	J Robert Flanagan	C/O Sagent Pharmaceuticals, Inc. 1901 North Roselle Road, Suite 700 Schaumburg IL 60195		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-09-16	500,000	$20.03	609,770	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,670	Direct
Common Stock	2,000	Indirect	See Footnote

Footnotes

These shares were sold by CNF Investments II LLC ("CNF") in the Issuer's public offering that closed on September 16, 2013. The price per share represents a price to the public of $21.25 per share, less underwriting commissions and discounts of $1.2218 per share.
The shares reported are held of record by CNF. Voting and investment decisions with respect to all shares held by CNF are exercised by its managing member, Mr. Flanagan. Accordingly, Mr. Flanagan may be deemed the beneficial owner of such shares.
The shares reported are held by Flanagan Family Limited Partnership. Mr. Flanagan is a managing member of E.O. Flanagan LLC, the general partner of Flanagan Family Limited Partnership.